Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

[1]  E. Pontali,et al.  COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom , 2022, Archivos de Bronconeumología.

[2]  R. Duarte,et al.  Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study , 2022, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[3]  R. Chaisson,et al.  The scientific response to TB – the other deadly global health emergency , 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  A. Rodríguez-Morales,et al.  The impact of the COVID-19 pandemic on tuberculosis services , 2021, International journal of mycobacteriology.

[5]  R. Duarte,et al.  Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study , 2021, European Respiratory Journal.

[6]  T. Cohen,et al.  The impact of COVID-19 on TB: a review of the data , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  F. Mello,et al.  Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? , 2021, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[8]  G. Ippolito,et al.  Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 , 2020, Emerging infectious diseases.

[9]  A. Spanevello,et al.  Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases , 2020, European Respiratory Journal.